Sawai Pharmaceutical Co., Ltd. provided earnings guidance for the fiscal year ending March 31, 2022. For the period, the company expects sales of JPY 196,400 million, Operating profit of JPY 26,400 million, Profit attributable to owners of parent of JPY 19,500 million and Basic earnings per share of JPY 445.30.